What’s New in Photon Counting CT?

October 15, 2026 · 9 articles · 10 research themes · covering October 08, 2026 – October 15, 2026

Overview

Across this week’s set of studies and reviews, photon-counting CT (PCD/PCCT) emerges as a platform for more reliable, material-specific imaging—especially where conventional CT struggles with subtle tissue differences or motion/technical artifacts. Multiple works focus on spectral/iodine-related capabilities: phantom experiments establish quantitative performance for iodine detection and quantification, while clinical studies in pancreatic cancer show that PCCT-derived iodine spectral metrics can separate locally recurrent PDAC from benign postoperative fibrosis in the surgical bed. Together, these results support a shift from purely morphologic follow-up toward quantitative, spectral biomarkers that may reduce diagnostic uncertainty after cancer surgery.

Methodology and image quality are also central themes. A reconstruction-based motion correction approach improves visualization of native and prosthetic heart valves on photon-counting CT, addressing a key barrier for cardiac assessment. In cerebrovascular imaging, a case report highlights how carotid web–like findings can be mimicked by CT acquisition/reconstruction factors, and it supports using ultra-high-resolution photon-counting CT to better discriminate true pathology from contrast mixing artifacts. Complementing these clinical efforts, phantom and temporal bone studies demonstrate that parameter optimization (e.g., slice thickness, filtration, reconstruction kernels) can substantially improve bone/implant visualization, reinforcing the practical importance of tailoring scan and reconstruction settings to the target anatomy.

Finally, the digest includes translational and clinical-context pieces: reviews outline how PCD-CT spectral features can be operationalized in oncology workflows, and another review synthesizes practical guidance on contrast agent selection and timing for elective oncologic imaging. In neurotology, temporal bone PCCT morphometrics of the vestibular aqueduct are linked to Ménière’s disease endotypes and hearing outcomes, illustrating how high-resolution photon-counting imaging can support imaging-based phenotyping and potentially more personalized prognosis.

---

Photon-counting CT physics & performance (phantoms/quantification)

Evaluation of iodine detection and quantification limits in photon-counting CT-a phantom study.

This phantom study quantified iodine detection and quantification limits for photon-counting CT (PCCT) versus dual-energy CT (DECT) by placing iodine test tubes (0.0–2.0 mg/mL) into head and abdominal-equivalent phantom setups and measuring noise, contrast-to-noise ratio, detection threshold, quantification precision, and linearity. The key finding was that iodine as an analyte can be characterized with laboratory-style performance metrics across PCCT and DECT, enabling determination of system-specific detection/quantification behavior over clinically relevant iodine concentrations. This is scientifically significant because it provides a rigorous framework for interpreting CT iodine maps and supports more reliable quantitative contrast assessment in practice.

Titternes R, Poludniowski G, Brismar TB et al. · European radiology experimental · (2026) · View on PubMed ↗ · Free PDF ↗

---

Carotid imaging & cerebrovascular CT angiography pitfalls

Ultra-high-resolution photon-counting CT argues against a suspected bilateral carotid web: a case report.

This case report studied whether a suspected bilateral carotid web in a 75-year-old woman with right-hemispheric transient ischemic attack was due to true pathology or CT acquisition/reconstruction artifacts, using dual-energy energy-integrating-detector CT (EID-CT) and stroke-protocol photon-counting detector CT (PCD-CT) with ultra-high-resolution photon-counting CT. The authors found a bilateral web-like appearance at the posterolateral carotid bulb region and evaluated how reconstruction/acquisition factors could produce or mimic the classic shelf-like CTA filling defect. The work is clinically significant because it highlights potential pitfalls in carotid web diagnosis and supports using ultra-high-resolution photon-counting CT to better discriminate true webs from flow-separation-related contrast mixing artifacts.

Ben-David E, Bogot NR, Berrebi Y et al. · Emergency radiology · (2026) · View on PubMed ↗

---

Cardiac imaging: valves and prosthesis assessment

Improved Visualization of Heart Valves With 4D-CT Using a Novel Motion Correction Algorithm.

This retrospective single-center study evaluated whether a novel reconstruction-based motion correction algorithm improves visualization of native and prosthetic heart valves on photon-counting detector CT (PCD-CT) compared with standard reconstructions in 57 patients. The key finding was that motion correction reduced motion artifacts and improved image quality for valvular assessment, particularly during phases of rapid cardiac motion. The clinical significance is that better valve visualization on PCD-CT could enhance detection and characterization of valvular pathology and improve confidence in assessing prosthetic valve function.

Zedler D, Demmert TT, Ritter A et al. · Investigative radiology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Oncology imaging: post-treatment surveillance (pancreas recurrence vs fibrosis)

Color K-edge imaging using spectral photon-counting CT with high-Z elements for lung functional imaging: A phantom study.

This retrospective pilot study assessed photon-counting CT (PCCT) spectral analysis parameters to differentiate locally recurrent pancreatic ductal adenocarcinoma (PDAC) from benign postsurgical fibrosis in 22 post-resection patients, using histopathology/FDG-avid tissue for recurrence and CA 19-9 stability with soft-tissue reduction for non-recurrence. The key result was that PCCT iodine-related spectral metrics derived from regions of interest in the surgical bed soft tissue differed between recurrence and fibrosis, enabling discrimination of local recurrence from benign postoperative changes. This is clinically significant because it suggests a noninvasive imaging approach to reduce diagnostic uncertainty after PDAC surgery, potentially guiding earlier and more accurate management decisions.

Gutwinska AJ, Rosario D, Robert A et al. · Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · (2026) · View on PubMed ↗ · Free PDF ↗

A Pilot Study of Photon Counting CT Spectral Analysis Following Pancreatic Adenocarcinoma Resection to Differentiate Local Recurrence From Postsurgical Fibrosis.

This study evaluated photon-counting CT spectral parameters after pancreatic adenocarcinoma resection to distinguish local recurrence from postsurgical fibrosis in 22 patients by measuring iodine density (I) and iodine normalized to aortic enhancement (I normalized to aortic enhancement). The authors found that PCCT-derived iodine-related spectral features in the surgical bed soft tissue differed between recurrent tumor and benign fibrosis, supporting spectral separation of these entities. The clinical significance is that PCCT may improve post-operative surveillance accuracy compared with conventional morphologic CT when recurrence is difficult to distinguish from scar tissue.

Platt S, Bansal B, Bagga B et al. · Journal of computer assisted tomography · (2026) · View on PubMed ↗

---

Oncology imaging: contrast agent selection & timing

[Contrast agent strategies in elective oncological imaging].

This article reviewed contrast agent strategies for elective oncological imaging, focusing on how intravenous contrast selection and timing (phase selection) affect detection and characterization of intraparenchymal lesions across CT and MRI. The key finding was a synthesis of practical considerations for choosing appropriate contrast phases and protocols in routine clinical practice relative to guideline recommendations. The clinical significance is that it helps standardize contrast-enhanced imaging approaches to improve lesion conspicuity and diagnostic consistency in oncology.

Gerwing M, Eisenblätter M · Radiologie (Heidelberg, Germany) · (2026) · View on PubMed ↗

---

Oncology imaging: PCD-CT clinical translation & workflow

Practical applications of photon-counting CT in oncology: an organ-based pictorial review.

This pictorial review summarized practical oncology applications of photon-counting detector CT (PCD-CT), contrasting it with dual-energy CT (DECT) on energy-integrating detector CT (EID-CT) platforms and focusing on material-specific imaging such as low-keV virtual monoenergetic imaging, iodine mapping, and material decomposition. The key message was that PCD-CT can mitigate some limitations of EID-CT-based DECT (e.g., low-keV noise and workflow complexity) while enabling improved tumor conspicuity and tissue characterization. The scientific significance is that it provides an organ-based framework for translating PCD-CT spectral capabilities into oncology imaging workflows.

Kawasaki Y, Yokoyama K, Hada H et al. · Insights into imaging · (2026) · View on PubMed ↗ · Free PDF ↗

---

Temporal bone & cochlear implant imaging

Improved assessment of the cochlear implant and temporal bone structures with ultra-high resolution photon-counting detector CT compared to conventional CT systems.

This phantom study evaluated image quality for cochlear implant and temporal bone visualization in post-mortem human specimen heads across three photon-counting detector CT (PCD-CT) systems (SOMATOM Edge, SOMATOM Force, NAEOTOM Alpha) compared with conventional CT, testing scan parameters including 120–150 kV, tin filtration, slice thickness 0.2–0.6 mm, and multiple reconstruction kernels. Photon-counting CT provided improved bone-to-soft-tissue contrast-to-noise performance (CNR) and better visualization of cochlear implant-related temporal bone structures at optimized parameters. The findings are scientifically and clinically significant because they support parameter selection for PCD-CT to improve temporal bone imaging quality relevant to cochlear implant assessment.

van der Bie J, van der Eerden AW, van den Berg AS et al. · European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · (2026) · View on PubMed ↗ · Free PDF ↗

---

Neurotology: Ménière’s disease endotyping with PCCT

Photon-counting CT based vestibular aqueduct trajectory analysis for the assessment of Ménière’s disease endotypes and hearing loss.

This retrospective study used temporal bone photon-counting CT (PCCT) in 106 patients (212 ears) and compared PCCT-derived vestibular aqueduct (VA) morphometric parameters with 3.0-T 3D-FLAIR MRI to identify Ménière’s disease (MD) endotypes and relate imaging biomarkers to hearing loss. The key finding was that PCCT-derived VA trajectory and morphologic visibility/width metrics (e.g., angular trajectory of the VA and VA visibility grade) were associated with MD endotypes and hearing outcomes. This is clinically significant because it supports imaging-based endotyping of MD using high-resolution PCCT, potentially enabling more personalized prognosis and management.

Wang J, Han Y, Xiang Y et al. · European journal of radiology · (2026) · View on PubMed ↗

---

---

Generated automatically on October 15, 2026. Covers PubMed articles published October 08, 2026 – October 15, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.